A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol

NCT01313143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Pharmacokinetics/Dynamics Study

Interventions

DRUG: AOP200704
DRUG: Esmolol hydrochloride, infusion

Sponsor

AOP Orphan Pharmaceuticals AG